CompoAtlas

Probiotic Winter Infection

Natural health product licensed in Canada

Other names
Immune Defense Probiotic, Winter, Winter 8B
Licence holder
WN Pharmaceuticals Ltd
NPN or DIN-HM
80080167
Status
Active licence
Licence date
20 September 2017
Revision date
3 September 2021
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Lactobacillus helveticus

Source : Cellule entière

5 Milliards d'UFCNot calculated
Lactobacillus helveticus

Source : R0419

5 Milliards d'UFCNot calculated
Bifidobacterium bifidum

Source : R-0071

3 Milliards d'UFCNot calculated
Bifidobacterium bifidum

Source : Cellule entière

3 Milliards d'UFCNot calculated

Non-medicinal ingredients

NA, Saccharose, Maltodextrine, Acide ascorbique, Fécule de pomme de terre, Extrait de Levure, Stéarate de magnésium, Eau purifiée

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Capsule1 Tous les jours
AdultesNot specified1 Capsuleminimum: 1 Tous les jours ; maximum: 2 Tous les jours
AdultesNot specified1 Capsule4 Tous les jours

Uses authorised in Canada

Helps support intestinal/gastrointestinal health. Could promote a favorable gut flora. Source of probiotics. Helps reduce the incidence of cold-like symptoms in stressed adults. Helps support immune defences against winter infections in healthy adults and in those having weakened immunity due to intensive sports activities. Helps to alleviate gastro-intestinal (GI) disturbances like flatulence, constipation, bloating and abdominal cramps in healthy adults. Promotes GI health, immune health and general well-being in physically active adults (including sporty individuals like athletes). Reduces symptoms associated with upper-respiratory tract illness (URTI). Helps shorten the duration of URTI episodes. Helps reduce the incidence of cold-like symptoms in adults with exercise-induced stress. Helps support the first line of the body's immune defenses (IgA production), which may be associated with lowering URTI risk in physically active adults (such as competitive athletes).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80080167

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging

List recorded in 2021. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line